AXIM Biotechnologies Competitors and Similar CompaniesClear all
AXIM Biotechnologies's competitors and similar companies include Trulieve, Versea, Kaya Holdings, Zynerba and Folium Biosciences.
 AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. |  Versea Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases. |  Kaya Holdings Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies. |  Zynerba Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. |  Folium Biosciences Folium Biosciences is a company specializing in the cultivation, extraction, and manufacturing of hemp-derived bulk CBD (cannabidiol) ingredients and finished products. | ||
Founding Date | Founding Date 2010 | Founding Date 2016 | Founding Date 2018 | Founding Date 1993 | Founding Date 2014 | Founding Date 2014 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | ||||||
Locations | Locations New York, US HQ San Diego, US | Locations North Fort Myers, US HQ Bradenton, US Edgewater, US Jacksonville, US Miami, US Orlando, US Pensacola, US see more | Locations Tampa, US HQ Belfast, GB Tampa, US | Locations Fort Lauderdale, US HQ Kallithea, GR Tzur Yitzhak, IL | Locations Devon, US HQ | Locations Colorado Springs, US HQ |
Employees | Employees 6 | Employees 4,455 | Employees 393% decrease | Employees 620% increase | Employees 2511% decrease | Employees 472% decrease |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 2.2 b | Valuation ($) N/A | Valuation ($) 1 m | Valuation ($) 70.1 m | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $39.5k (FY, 2023) | Revenue (est.) $1.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $7.1k (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $470m (FY, 2025) | Cost of goods N/A | Cost of goods $7.5k (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $711.2m (FY, 2025) | Gross profit N/A | Gross profit ($366) (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($8.1m) (FY, 2023) | Net income ($122.2m) (FY, 2025) | Net income N/A | Net income ($2.2m) (FY, 2024) | Net income ($35m) (FY, 2022) | Net income N/A |
Funding | ||||||
Total funding raised | Total funding raised $ 115k | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 16.5m | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Trulieve
HQ
North Fort Myers, US
Employees
4,455
Trulieve is a medical marijuana dispensing organization.
View companyVersea
HQ
Tampa, US
Employees
39↓ 3% decrease
Versea Holdings is a pharmaceutical company focused on the development of molecules for the treatment of inflammatory and other debilitating diseases.
View companyKaya Holdings
HQ
Fort Lauderdale, US
Employees
6↑ 20% increase
Kaya Holdings owns and operates brands that produce, distribute and sell premium cannabis products, including flower, concentrates, and cannabis-infused baked goods and candies.
View companyZynerba
HQ
Devon, US
Employees
25↓ 11% decrease
Zynerba Pharmaceuticals is a company developing transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions.
View company